GlassScriptPhysician profile
George Marshall
NPI 1861803082
$18,892.86
in general payments reported to CMS, 2019-2025
11 companies · $54.21 in 2025
The $54.21 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.59 · 2022: $18K · 2023: $525 · 2024: $345 · 2025: $54.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Travel and Lodging: $37.00 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.34 |
| Travel and Lodging | $37.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,070.35 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,078.51 | 2021-2023 | Ribfix Blu Advantage |
| Tela Bio, INC. | $279.92 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $163.34 | 2023 | Phasix Mesh |
| Stryker Corporation | $162.41 | 2023 | Spy-Phi System |
| Csl Behring | $46.23 | 2023-2024 | Kcentra |
| Kerecis Limited | $33.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $17.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $15.76 | 2024 | Spyglass Discover |
| W. L. Gore & Associates, INC. | $13.21 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Kls-Martin L.P. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.